Small molecules for treatment of hypercholesterolemia and related diseases

Details for Australian Patent Application No. 2005255012 (hide)

Owner Avanir Pharmaceuticals

Inventors Khatuya, Haripada; Alisala, Kashinatham; Sircar, Jagadish C.; Thomas, J. Richard; Vassar, Victor Charles; Nikoulin, Igor

Agent Davies Collison Cave

Pub. Number AU-A-2005255012

PCT Pub. Number WO2005/123700

Priority 60/578,228 09.06.04 US

Filing date 9 June 2005

Wipo publication date 29 December 2005

International Classifications

C07C 237/22 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07C 279/18 (2006.01) Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups

C07D 209/16 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123700 Priority application(s): WO2005/123700

18 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005255013-Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia

2005255011-Heterocyclic derivatives for treatment of hyperlipidemia and related diseases